Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong · Delayed Price · Currency is HKD 70.05
-4.00 (-5.40%)
At close: Feb 13, 2026
Suzhou Ribo Life Science Revenue
In the year 2024, Suzhou Ribo Life Science had annual revenue of 142.63M CNY with 324,052.27% growth. Suzhou Ribo Life Science had revenue of 51.91M in the quarter ending June 30, 2025, with 56.57% growth.
Revenue
142.63M CNY
Revenue Growth
+324,052.27%
P/S Ratio
60.53
Revenue / Employee
353.04K CNY
Employees
404
Market Cap
11.95B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 142.63M | 142.58M | 324,052.27% |
| Dec 31, 2023 | 44.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| VSTECS Holdings | 94.52B |
| China Foods | 24.58B |
| Allied Group | 14.19B |
| China Modern Dairy Holdings | 14.14B |
| Zhongyuan Bank | 13.88B |
| 361 Degrees International | 11.66B |
| Mongolian Mining | 6.64B |
| Butong Group | 1.53B |